AIG Hospitals
Hyderabad, Telangana, 500032, India
Location status: Recruiting
Location contact
Deepa Shukla, PhD
CONTACT
Hardik Rughwani, MD, DM
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07283185
MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Hyderabad, Telangana, 500032, India
Location status: Recruiting
Deepa Shukla, PhD
CONTACT
Hardik Rughwani, MD, DM
PRINCIPAL_INVESTIGATOR
MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures. Prior research confirms that diagnostic EUS generates significantly less CO₂e per procedure compared to radiologic imaging. This study aims to support sustainable diagnostic choices by quantifying their environmental footprint.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Total kg CO₂e per procedure for EUS vs MRCP.
Time frame: 12 months
Emissions per accurate diagnosis Emissions broken down by source (electricity, consumables, travel) Recommendations for sustainable diagnostic practices
Contact information is provided by the study sponsor or research team.
Asian Institute of Gastroenterology, India
Other
Prospective Comparison of the Carbon Footprint of Endoscopic Ultrasound (EUS) vs Magnetic Resonance Cholangiopancreatography (MRCP) for Evaluation of Suspected Choledocholithiasis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05141916
Bile Duct Diseases, Biliary Disease
Calgary, Alberta, Canada
View Trial DetailsNCT07418112
Bile Duct Diseases, Biliary Tract Diseases
Chicago, Illinois, United States
View Trial DetailsNCT07407491
Acute Cholangitis, Bile Duct Diseases
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT06066372
Bile Duct Diseases, Biliary Tract Diseases
Hyderabad, Telangana, India
View Trial Details